Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
3
Bearish filings
6
Named actors
9
Disclosed $ (bull / bear)
$0 / $84K
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-31 | Activist (13D) Sermonix Pharmaceuticals, Inc. | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-20 | 5%+ holder (13G) — increased stake ACORN BIOVENTURES, L.P. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) ADAR1 Capital Management, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-04 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) Mark James Litton | filed notice to sell | $28K | SEC ↗ |
| 2026-03-04 | PRESIDENT and CEO Litton Mark James | sold | $28K |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-03-04 | CHIEF MEDICAL OFFICER San Martin Javier | sold | $9K | SEC ↗ |
| 2026-03-04 | CHIEF SCIENTIFIC OFFICER CHURCH KEVIN | sold | $7K | SEC ↗ |
| 2026-03-04 | GENERAL COUNSEL and CCO Worthington Mark | sold | $7K | SEC ↗ |
| 2026-03-04 | CHIEF FINANCIAL OFFICER Renninger Robert | sold | $5K | SEC ↗ |